Spots Global Cancer Trial Database for adult grade i meningioma

Every month we try and update this database with for adult grade i meningioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors	NCT00499798	Brain and Centr... Chemotherapeuti... Infertility		18 Years - 60 Years	Wake Forest University Health Sciences
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma	NCT00348790	Brain and Centr... Sarcoma	vatalanib	18 Years -	Northwestern University
Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma	NCT00006119	Brain and Centr...	hydroxyurea	16 Years - 120 Years	UNICANCER
Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery	NCT00104936	Brain and Centr...	adjuvant therap... radiation thera... stereotactic ra...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors	NCT00110032	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Central N... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Grade III... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Pilocytic... Adult Pineoblas... Adult Pineocyto... Adult Subependy... Adult Supratent... Meningeal Melan...	EF5 conventional su... positron emissi... fluorine F 18 E... pharmacological...	18 Years -	National Cancer Institute (NCI)
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma	NCT01119599	Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Primary M... Adult Subependy... Adult Subependy... Adult Supratent... Malignant Adult...	3-Dimensional C... Gamma-Secretase... Intensity-Modul... Laboratory Biom... Pharmacological... Temozolomide Therapeutic Con...	19 Years -	National Cancer Institute (NCI)
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors	NCT00967200	Central Nervous...	laboratory biom... pharmacogenomic...	18 Years - 120 Years	University Hospital, Montpellier
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma	NCT00003590	Adult Meningiom...	hydroxyurea	18 Years - 120 Years	SWOG Cancer Research Network
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma	NCT00895622	Brain and Centr...	54 Gy radiother... 60 Gy radiother...	18 Years -	Radiation Therapy Oncology Group
Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma	NCT00904735	Brain and Centr...	hydroxyurea imatinib mesyla...	18 Years - 75 Years	National Cancer Institute (NCI)
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma	NCT00348790	Brain and Centr... Sarcoma	vatalanib	18 Years -	Northwestern University
Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma	NCT00904735	Brain and Centr...	hydroxyurea imatinib mesyla...	18 Years - 75 Years	National Cancer Institute (NCI)
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	NCT01125046	Acoustic Schwan... Adult Anaplasti... Adult Ependymom... Adult Grade I M... Adult Grade II ... Adult Meningeal... Adult Papillary... Neurofibromatos... Neurofibromatos... Recurrent Adult...	bevacizumab	18 Years -	Northwestern University
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders	NCT00255671	Brain and Centr... Metastatic Canc... Radiation Toxic...	Questionnaire	18 Years -	Case Comprehensive Cancer Center
Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors	NCT00025675	Brain and Centr...	gefitinib	18 Years - 120 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	NCT01125046	Acoustic Schwan... Adult Anaplasti... Adult Ependymom... Adult Grade I M... Adult Grade II ... Adult Meningeal... Adult Papillary... Neurofibromatos... Neurofibromatos... Recurrent Adult...	bevacizumab	18 Years -	Northwestern University
Imatinib Mesylate in Treating Patients With Recurrent Meningioma	NCT00045734	Adult Grade I M... Adult Grade II ... Adult Grade III... Adult Meningeal... Adult Meningiom... Recurrent Adult...	imatinib mesyla... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment	NCT00544284	Brain and Centr... Lymphoma Metastatic Canc... Unspecified Adu...	bortezomib temozolomide pharmacological...	18 Years -	City of Hope Medical Center
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors	NCT02194452	Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Subependy... Adult Subependy... Adult Supratent... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Supra... Meningeal Melan... Newly Diagnosed... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child...	gallium Ga 68-e... positron emissi... computed tomogr... laboratory biom...	6 Months - 29 Years	University of Iowa
Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma	NCT00354913	Glioblastoma Gliosarcoma	hydroxyurea imatinib mesyla...	18 Years -	Duke University
Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery	NCT00104936	Brain and Centr...	adjuvant therap... radiation thera... stereotactic ra...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	NCT01125046	Acoustic Schwan... Adult Anaplasti... Adult Ependymom... Adult Grade I M... Adult Grade II ... Adult Meningeal... Adult Papillary... Neurofibromatos... Neurofibromatos... Recurrent Adult...	bevacizumab	18 Years -	Northwestern University
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma	NCT00895622	Brain and Centr...	54 Gy radiother... 60 Gy radiother...	18 Years -	Radiation Therapy Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: